What MedSleuth does

MedSleuth is a San Francisco-based healthcare technology company that develops the BREEZE™ platform, a clinically-validated, cloud-based web application that collects medical histories directly from patients using proprietary clinical algorithms and a medication-driven recall methodology. The platform is delivered as four integrated modules — BREEZE Transplant (full transplant continuum from referral through donor/recipient follow-up and UNOS/CMS compliance), KidneyMatchgrid (paired kidney donation matching via a partnership with the Alliance for Paired Kidney Donation, powered by a Nobel Prize-winning optimization algorithm), BREEZE Clinical Trials (remote screening, enrollment, adverse event monitoring, and FDA REMS compliance for pharma sponsors and trial sites), and BREEZE Preoperative (standardized perioperative risk assessment for hospitals and surgical centers).

The company serves a focused set of U.S. institutional customers — transplant centers, hospitals, surgical centers, and clinical trial sponsors — through a consultative enterprise sales motion with demo requests and quote-based pricing on annual subscriptions. The platform integrates with customer EHRs, is HIPAA-compliant, holds SOC 2 Type II certification, and has been validated by the U.S. Department of Defense and the National Institutes of Health. Despite operating with a micro team of 1–10 employees, MedSleuth has positioned the BREEZE platform across multiple high-value clinical workflows, with product and partnership expansion activity concentrated in 2025 and an apparent structural linkage to DaVita indicated by privacy notice domains hosted at davita.com.

Name

MedSleuth

Legal name

MedSleuth, Inc.

Website

https://medsleuth.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

1–10 employees

Short description

MedSleuth builds the BREEZE™ cloud platform, which collects patient medical histories and supports U.S. transplant centers, hospitals, surgical centers, and clinical trial sponsors with modules for transplant management, kidney paired donation matching (via APKD), clinical trial enrollment, and preoperative risk assessment.

Ownership category

akta.pro rank

Product category

Healthcare Workflow Software

NAICS

Computer Systems Design and Related Services (54151), Home Health Care Services (621610)

SIC

Services-Prepackaged Software (7372), Services-Health Services (8000)

akta.pro primary industry

Connected Therapeutics & Smart Drug Delivery Monitoring (HLACAFAL)

akta.pro secondary industry

Medication Adherence & Smart Drug Delivery (Connected Inhalers, Pens, Pill Dispensers) (HLACAPAH)

Keywords

• Healthcare workflow software
• Transplant management software
• Preoperative assessment platform
• Clinical trial patient screening
• Medical history automation

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. BREEZE™ Software Licensing: Enterprise software licensing model for BREEZE™ platform deployed to healthcare providers including transplant centers, hospitals, and clinical trial sites. The platform appears to be sold as a subscription-based or per-transaction model targeting institutional healthcare customers.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

MedSleuth develops and sells the BREEZE™ web-based platform, a clinically-validated software suite that automates medical history collection, patient eligibility screening, and clinical workflow management for transplant centers, hospitals, surgical centers, and clinical trial sponsors. The suite includes specialized modules for transplant management (BREEZE Transplant™), kidney donor-recipient matching (KidneyMatchgrid), preoperative assessment (BREEZE™ Preoperative), and clinical trial patient onboarding (BREEZE™ Clinical Trials).

Product overview

MedSleuth is a unified healthcare technology platform built around its core BREEZE™ software product. The platform consists of multiple integrated modules: BREEZE Transplant™ for managing the full kidney transplant continuum from referral through follow-up; KidneyMatchgrid, a kidney matching tool developed in partnership with APKD that uses a Nobel Prize-winning algorithm for paired donation optimization; BREEZE™ Clinical Trials for patient enrollment and REMS compliance; and BREEZE™ Preoperative for standardized preoperative risk assessment. All modules share the same web-based platform architecture for collecting medical histories directly from patients.

Differentiator

Problem solved

Functional benefit

Brands

• BREEZE: A clinically-validated web-based platform for collecting medical histories directly from patients, used for transplant management, preoperative assessments, and clinical trials. Includes modules for recipient referral, candidate evaluation, waitlist management, living donor evaluation, and follow-up.
• KidneyMatchgrid

Products and services

• BREEZE™ Clinical Platform
• BREEZE Transplant™
• KidneyMatchgrid
• BREEZE™ Preoperative
• BREEZE™ Clinical Trials

Quantifiable outcome

• 97% Ease of Use rating from users
• +5 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature5 records

Partnerships

One partnership is on record.

• Alliance for Paired Kidney Donation (APKD)coreStrategic or Co-development PartnerMedSleuth partners with APKD to offer KidneyMatchgrid in the U.S., providing sophisticated matching software that gives transplant centers enhanced access to internal, regional and national matches with dedicated concierge-level support throughout the kidney donation process. The partnership leverages MedSleuth's technology platform with APKD's donor protection programs including DonorProtect benefits, APKD Kidney Promise, and KidneyPledge offerings.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Emerging players

• Deep 6 AI: AI-driven patient-trial matching platform using EHR data, comparable to BREEZE Clinical Trials for site selection and patient enrollment in pharma-sponsored studies.
• TriNetX: Clinical trial patient-matching platform that uses EHR data to identify eligible patients for trials, an emerging alternative to MedSleuth's BREEZE Clinical Trials in site selection and enrollment.
• Mendel: AI-powered clinical trial matching platform that structures medical records for patient-trial eligibility, emerging as a partial substitute for BREEZE Clinical Trials in pharma recruitment workflows.

Direct peers

• Transplant Connect: Provides transplant-specific software for organ procurement organizations and transplant centers, directly competing with MedSleuth's BREEZE Transplant module in the same customer base.
• Phreesia: Patient intake and pre-visit workflow platform used by hospitals and health systems, directly competing with MedSleuth's BREEZE Preoperative module for patient history collection and preoperative assessment.

Broad incumbents

• Veeva Systems: Large enterprise cloud software provider for life sciences, including clinical trial management and patient engagement tools, competing broadly with MedSleuth's Clinical Trials/REMS module in the pharma and CRO market.
• IQVIA: Global leader in clinical research services and technology, offering site selection, patient recruitment, and trial management platforms that overlap with BREEZE Clinical Trials.
• Medidata Solutions: Dassault Systèmes subsidiary providing clinical trial technology including electronic data capture and patient engagement, competing with BREEZE Clinical Trials in the pharma and biotech customer segment.
• Epic Systems: Dominant EHR vendor whose platform MedSleuth integrates with; Epic could choose to build competing transplant and preoperative workflows in-house, threatening MedSleuth's integration-dependent position.
• Oracle Health: Oracle's healthcare division (formerly Cerner) is a major EHR vendor whose transplant and clinical workflow capabilities could compete with MedSleuth's modules at large hospital customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MedSleuth